Optimata is a participant in the Drug Disease Model Resources (DDMoRe) consortium, which was founded in 2011 by pharma partners, academics and SMEs across Europe. DDMoRe develops a public drug and disease model repository supported by an open source interoperability framework which will provide access to existing and future modeling tools. DDMoRe aims to facilitate efficient exchange and re-use of knowledge between all stakeholders—a gold standard for collaborative drug and disease modeling and simulation. The set of standards developed by DDMoRe will be designed both for model and workflow encoding, as well as for storage and transfer of models and their associated metadata. The project is supported by the European Union’s Seventh Framework Program (FP7) and European Federation of Pharmaceutical Industries and Associations’ companies (DDMoRe; EFPIA; FP7/2007-2013; contract #115156), under the Innovative Medical Initiative (IMI), a large-scale public-private partnership between the European Union and the pharmaceutical industry association EFPIA.